Back to the search results

Klinikum Fulda - Hauptstandort

Klinikum Fulda - Hauptstandort
Klinikum Fulda - Hauptstandort

Pacelliallee 4
36043 Fulda

Phone: 0661-84-0
Fax: 0661-84-5013
Mail: ed.adluf-mukinilk@ofni

  • Number of beds: 952
  • Number of specialist departments: 29
  • Number of inpatient cases: 35.600
  • Number of partial inpatient cases: 517
  • Number of outpatient cases: 47.676
  • Hospital owners: Klinikum Fulda gemeinnützige Aktiengesellschaft
  • Type of provider: öffentlich
Further information
Bezeichnung
Teilnahme externe Qualitätssicherung yes
Bezeichnung
Teilnahme externe Qualitätssicherung yes
Bezeichnung
Teilnahme externe Qualitätssicherung yes
Quantity performed 19
Exception? No exception
Quantity performed 57
Exception? No exception
Quantity performed 24
Exception? No exception
Quantity performed 15
Exception? No exception
Quantity performed 32
Exception? No exception
Overall result forecast presentation: yes
Quantity performed reporting year: 57
Quantity forecast year: 74
Examination by state associations? yes
Exemption? no
Result of the examination by the federal state authorities? no
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 24
Quantity forecast year: 19
Examination by state associations? yes
Exemption? no
Result of the examination by the federal state authorities? no
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 32
Quantity forecast year: 26
Examination by state associations? yes
Exemption? no
Result of the examination by the federal state authorities? no
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 15
Quantity forecast year: 13
Examination by state associations? yes
Exemption? no
Result of the examination by the federal state authorities? no
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 19
Quantity forecast year: 16
Examination by state associations? yes
Exemption? no
Result of the examination by the federal state authorities? no
Transitional arrangement? no
No. Explanation
CQ18 Measures for quality assurance of positron emission tomography in patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma for interim staging after chemotherapy to decide on the continuation of therapy (Amended by resolution of July 15, 2021, see CQ29).
CQ25 Measures for quality assurance in the performance of minimally invasive heart valve interventions pursuant to Article 136, para. 1, sentence 1, number 2 for hospitals licensed in accordance with Article 108 of the SGB V
CQ30 Quality assurance guideline for interstitial LDR brachytherapy for low-risk localized prostate cancer (effective January 8, 2021).
CQ05 Measures for quality assurance in the care of pre-term and full-term neonates – Perinatal Centre LEVEL 1
CQ22 Quality assurance measures for interstitial low-dose-rate brachytherapy for the treatment of localised prostate cancer (These QA measures will expire at the end of January 7, 2021).
CQ03 Quality assurance measures for the implementation of positron emission tomography (PET) in hospitals for the indications non-small-cell lung cancer (NSCLC) and solid pulmonary nodules
CQ01 Quality assurance measures for inpatient care with the indication abdominal aortic aneurysm
CQ27 Guideline on quality assurance measures for inpatient care with bronchoscopic lung volume reduction procedures for severe emphysema (QS Guideline bronchoscopic LVR /QS-RL BLVR)
CQ28 Guideline on quality assurance measures for liposuction procedures for stage III lipedema (QS-RL Liposuction)
  • Clarifying chat completed: no
  • Clarifying chat not completed: no
  • No participation in clarifying chat: no
  • Notification of non-fulfilment of nursing care not made: yes
Number Group
251 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
239 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
198 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”
  • Drug commission
  • Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
  • Zubereitung durch pharmazeutisches Personal
  • Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen
  • Patientenindividuelle Zubereitung der totalen parenteralen Ernährung und der Antibiotikazubereitung in der Kinderklinik durch die Apotheke
  • Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)
  • Fallbesprechungen
  • Maßnahmen zur Vermeidung von Arzneimittelverwechslung
  • Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
  • Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
  • Sonstige Konzepte: DokuPik (Bundesverband Deutscher Krankenhausapotheker)
  • Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
  • Aushändigung von Patienteninformationen zur Umsetzung von Therapieempfehlungen
  • Aushändigung des Medikationsplans
  • bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten
Job
Explanation

Universitätsmedizin Marburg - Campus Fulda ; Universitäre Lehre Humanmedizin: 2. und 3. klinisches Studienjahr ( 7.-10. Semester) und Praktisches Jahr

Explanation

Explanation

Explanation

Explanation

Explanation

Explanation

Explanation

Explanation

Training in other healing professions
Comment

Comment

Comment

Comment

Comment

Comment

Mathilde Purtauf

Patientenfürsprecherin

Pacelliallee 4
36043 Fulda

Phone: 0661-84-6652
Mail: ed.adluf-mukinilk@ofni

Leo Zehkorn (ab November 2021)

Patientenfürsprecher

Pacelliallee 4
36043 Fulda

Phone: 0661-84-6652
Mail: ed.adluf-mukinilk@ofni

Assessorin Bärbel Schwalm

Leiterin Stabsstelle Recht und Compliance

Pacelliallee 4
36043 Fulda

Phone: 0661-84-5130
Mail: ed.adluf-mukinilk@mlawhcs.lebreab

Boris Krah

Leiter Qualitäts- und Risikomanagement

Pacelliallee 4
36043 Fulda

Phone: 0661-84-5131
Mail: ed.adluf-mukinilk@hark.sirob

Heil Stefanie

Leiterin Qualitäts- und Risikomanagement (kommissarisch)

Pacelliallee 4
36043 Fulda

Phone: 0661-84-5131
Mail: ed.adluf-mukinilk@lieh.einafets

Priv.-Doz. Dr. med. Thomas Menzel

Vorstand Krankenversorgung

Pacelliallee 4
36043 Fulda

Phone: --

Prof. Dr. Roland Radziwill

Direktor Apotheke

Pacelliallee 4
36043 Fulda

Phone: 0661-84-6430
Mail: ed.adluf-mukinilk@lliwizdaR.dnaloR

Mathilde Purtauf

Patientenfürsprecherin

Pacelliallee 4
36043 Fulda

Phone: 0661-84-6652
Mail: ed.adluf-mukinilk@ofni

Pacelliallee 4
36043 Fulda

Phone: 0661-84-0
Fax: 0661-84-5013
Mail: ed.adluf-mukinilk@ofni

Ronald Petrovic-Poljak

Pflegedirektor

Pacelliallee 4
36043 Fulda

Phone: 0661-84-5023
Mail: ed.adluf-mukinilk@LDP

Burkhard Bingel

Vorstand Administration

Pacelliallee 4
36043 Fulda

Phone: 0661-84-5017
Mail: ed.adluf-mukinilk@ofni

Priv. Doz. Dr. med. Thomas P. Menzel

Vorstand Krankenversorgung (Vorstandssprecher)

Pacelliallee 4
36043 Fulda

Phone: 0661-84-5011
Mail: ed.adluf-mukinilk@ofni

Priv.-Doz. Dr. med. Thomas Menzel

Vorstand Krankenversorgung

Pacelliallee 4
36043 Fulda

Phone: 0661-84-5011
Mail: ed.adluf-mukinilk@ofni

IK: 260620157

Location number: 772145000

Old location number: 772145000